Haibo Xu

Key Laboratory Of Medical Reprogramming Technology
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway.

PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway.

Journal: Cancer discovery

Published: June 18, 2024

Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.

Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.

Journal: Oncogene

Published: February 07, 2024

Engineering redirected NF-κB/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer.

Engineering redirected NF-κB/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer.

Journal: Science bulletin

Published: May 07, 2023

Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray.

Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray.

Journal: Acta biochimica et biophysica Sinica

Published: February 15, 2023

Patient-derived renal cell carcinoma organoids for personalized cancer therapy.

Patient-derived renal cell carcinoma organoids for personalized cancer therapy.

Journal: Clinical and translational medicine

Published: March 27, 2022

Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21-5p/TGFBR2/P38/EGR1 Axis.

Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21-5p/TGFBR2/P38/EGR1 Axis.

Journal: Molecular cancer research : MCR

Published: March 02, 2022

Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening.

Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 10, 2021

Single-cell profiling of long noncoding RNAs and their cell lineage commitment roles via RNA-DNA-DNA triplex formation in mammary epithelium.

Single-cell profiling of long noncoding RNAs and their cell lineage commitment roles via RNA-DNA-DNA triplex formation in mammary epithelium.

Journal: Stem cells (Dayton, Ohio)

Published: April 28, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026